CDRE: Cadre Holdings, Inc. Stock

by  •  • Comments Off on CDRE: Cadre Holdings, Inc. Stock

SIC 3842 – Orthopedic, Prosthetic, and Surgical Appliances and Supplies

Valuation
Market Cap ($M) 1,193.47
Enterprise Value ($M) 1,291.74
Book Value ($M) 311.51
Book Value / Share 7.67
Price / Book 3.83
NCAV ($M) -13.63
NCAV / Share -0.34
Price / NCAV -87.58

Profitability (mra)
Return on Invested Capital (ROIC) 0.07
Return on Assets (ROA) 0.06
Return on Equity (ROE) 0.13

Liquidity (mrq)
Quick Ratio 2.61
Current Ratio 3.48

Balance Sheet (mrq) ($M)
Current Assets 327.57
Assets 652.71
Liabilities 341.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 567.56
Operating Income 78.38
Net Income 36.13
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 31.78
Cash from Investing -147.43
Cash from Financing 152.67

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-11 13G/A Kanders Warren B 31.30 -15.08
11-12 13G/A Fmr Llc 11.15 -10.83
11-08 13G BlackRock, Inc. 6.30 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended: September 30, 2024 ☐ Transition Report Pursuan
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended: June 30, 2024 ☐ Transition Report Pursuant to
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended: March 31, 2024 ☐ Transition Report Pursuant to

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-24 23,523 170,920 13.76
2025-04-23 20,728 179,893 11.52
2025-04-22 23,624 185,524 12.73
2025-04-21 55,416 323,639 17.12

(click for more detail)

Similar Companies
BDX – Becton, Dickinson and Company BFLY – Butterfly Network, Inc.
BSX – Boston Scientific Corporation CNMD – CONMED Corporation
ENOV – Enovis Corporation


Financial data and stock pages provided by
Fintel.io